Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You have been diagnosed with lung cancer confirmed by a laboratory tissue test
- You have received at least one dose of an approved immunotherapy (immune checkpoint inhibitor) drug for lung cancer in China
- You have signed a form giving your consent to participate in the study
Who may not be able to join:
- You have been diagnosed with two or more separate primary (original) cancers
- Important information about your health or treatment history is unavailable or incomplete
- You are unable to attend or complete the required follow-up appointments or check-ins during the study
- You had a blood clot in a vein or artery (such as a deep vein thrombosis, pulmonary embolism, stroke, or heart attack) at the time you first started immunotherapy treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86+13520108369
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Immune checkpoint inhibitor-associated venous thromboembolism/arterial thromboembolism
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.